Plant secondary metabolites- Potent inhibitors of monoamine oxidase isoforms

Central Nervous System Agents in Medicinal Chemistry

Volumn 14, Issue 1, 2014, Pages 28-33

  Mathew, Bijo ^a   Suresh, Jerad ^b   Mathew, Githa E ^c   Parasuraman, Ramamoorthy ^a   Abdulla, Nalakathu ^d  

^a Grace College of Pharmacy   (India)

^b MADRAS MEDICAL COLLEGE   (India)

^c Grace College of Pharmacy   (India)

^d Malik Deenar College of Pharmacy   (India)

Author keywords

Alkaloids; Flavonoids; Monoamine oxidase inhibitors; Xanthones

Indexed keywords

5 HYDROXYFLAVANONE; ACACETIN; ALKALOID; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; APIGENIN; BERBERINE; BETA CARBOLINE; CATECHIN; CHELIDONINE; CHRYSIN; DIOSMETIN; EPICATECHIN; ERIODICTYOL; FLAVONOID; FORMONONETIN; GLYCOSIDE; JATRORRHIZINE; KAEMPFEROL; KUSHENOL; LUTEOLIN; MONOAMINE OXIDASE INHIBITOR; NARINGENIN; PALMATINE; PIPERINE; QUERCETIN; SANGUINARINE; SOPHORA FLAVESCENS EXTRACT; UNCLASSIFIED DRUG; UNINDEXED DRUG; XANTHONE DERIVATIVE; AMINE OXIDASE (FLAVIN CONTAINING); FLAVONE DERIVATIVE; PLANT EXTRACT;

ARTICLE; CHRYSANTHEMUM INDICUM; ENZYME INHIBITION; GENTIANA LUTEA; GINKGO BILOBA; HUMAN; HYDROGEN BOND; IC50; METABOLITE; MOLECULAR DOCKING; NONHUMAN; STRUCTURE ACTIVITY RELATION; ANIMAL; CHEMISTRY; METABOLISM; NEURODEGENERATIVE DISEASES;

ALKALOIDS; ANIMALS; FLAVONES; HUMANS; MONOAMINE OXIDASE; MONOAMINE OXIDASE INHIBITORS; NEURODEGENERATIVE DISEASES; PLANT EXTRACTS;

EID: 84919719507     PISSN: 18715249     EISSN: 18756166     Source Type: Journal    
DOI: 10.2174/1871524914666140826111930     Document Type: Article

References (47)

1. Edmondson, D. E.; Binda, C.; Mattevi, A. Structural insights into the mechanism of amine oxidation by monoamine oxidases A and B. Arch. Biochem. Biophys., 2007, 464, 269-276.
2. Secci, D.; Bolasco, A.; Chimenti, P.; Carradori, S. The state of the art of pyrazole derivatives as monoamine oxidase inhibitors and antidepressant/anticonvulsant agents. Curr. Med. Chem., 2011, 18, 5114-5144.
3. Bach, A. W; Lan, N. C; Johnson, D. L; Abell, C. W; Bembenek, M. E; Kwan, S. W; Seeburg, P. H; Shih, J. C. cDNA cloning of human monoamine oxidase A and B: Molecular basis of differences in enzymatic properties. Proc. Natl. Acad. Sci. U. S. A., 1988, 85, 4934-4938.
4. Hubálek, F.; Binda, C.; Khalil, A.; Li, M.; Mattevi, A.; Castagnoli, N.; Edmondson, D. E. Demonstration of isoleucine 199 as a structural determinant for the selective inhibition of human monoamine oxidase B by specific reversible inhibitors. J. Biol. Chem., 2005, 280, 15761-15766.
5. Son, S. Y.; Ma, J.; Kondou, Y.; Yoshimura, M.; Yamashita, E.; Tsukihara, T. Structure of human monoamine oxidase A at 2. 2 Å resolution: the control of opening the entry for substrates/inhibitors. Proc. Natl. Acad. Sci. U. S. A., 2008, 105, 5739-5744.
6. Binda, C.; Wang, J.; Pisani, L.; Caccia, C.; Carotti, A.; Salvati, P.; Edmondson, D. E.; Mattevi, A. Structures of human monoamine oxidase B complexes with selective non-covalent inhibitors: safinamide and coumarin analogs. J. Med. Chem., 2007, 50, 5848-5852.
7. Pacher, P.; Kecskemeti, V.; Trends in the development of new antidepressants. Is there a light at the end of tunnel? Curr. Med. Chem., 2004, 11, 925-943.
8. Yamada, M.; Yasuhara, H. Clinical pharmacology of MAO inhibitors: safety and future. Neurotoxicology, 2004, 25, 215-221.
9. Carreiras, M. C.; Marco, J. L. Recent approaches to novel anti-Alzheimer's therapy. Curr. Pharm. Des., 2004, 10, 3167-3175.
10. Fernandez, H. H.; Chen, J. J. Monoamine oxidase-B inhibition in the Parkinson's disease. Pharmacotherapy, 2007, 27, 174S-185S.
11. Chimenti, F.; Bolasco, A.; Manna, F.; Secci, D.; Chimenti, P.; Befani, O. Synthesis and selective inhibitory activity of 1-acetyl-3, 5-diphenyl-4, 5-dihydro-(1h)-pyrazole derivatives against monoamine oxidase. J. Med. Chem., 2004, 47, 2071-2074.
12. Ucar, G.; Gokhan, N.; Yesilada, A.; Bilgin, A. A. 1-N-Substituted thiocarbamoyl-3-phenyl-5-thienyl-2-pyrazolines: A novel cholinesterase and selective monoamine oxidase B inhibitors for the treatment of Parkinson's and Alzheimer's diseases. Neurosci. Lett., 2005, 382, 327-331.
13. Karuppasamy, M.; Mahapatra, M.; Yabanoglu, S.; Ucar, G.; Sinha, BN.; Basu, A.; Mishra, N.; Sharon, A.; Kulandaivelu, U.; Jayaprakash, V. Development of selective and reversible pyrazoline based MAO-A inhibitors: Synthesis, biological evaluation and docking studies. Bioorg. Med. Chem., 2010, 18, 1875-1881.
14. Goksen, U. S.; Ciftci, S. Y.; Ercan, A.; Yelekci, K.; Ucar, G.; Kelekci, N. G. Evaluation of selective MAO inhibitory activities of some novel pyrazolines derivatives. J. Neural. Transm., 2013, 120, 863-873.
15. Mathew, B.; Suresh, J.; Anbazhagan, S.; Mathew, G. E. Pyrazoline: A promising scaffold for the inhibition of Monoamine oxidase. Cent. Nerv. Syst. Agents Med. Chem., 2013, 13, 195-206.
16. Abdelhafez, O. M.; Amin, K. M.; Ali, H. I.; Abdalla, M. M.; Batran, R. Z. Synthesis of new 7-Oxycoumarin derivatives as potent and selective Monoamine oxidase A inhibitors. J. Med. Chem., 2012, 55, 10424-10436.
17. Abdelhafez, O. M.; Amin, K. M.; Ali, H. I.; Abdalla, M. M.; Batran, R. Z. Monoamine oxidase A and B inhibiting effect and molecular modeling of some synthesized coumarin derivatives. Neurochem. Int., 2013, 62, 198-209.
18. Delogu, G.; Picciau, C.; Ferino, G.; Quezada, E.; Podda, G.; Uriarte, E. Synthesis, human oxidase inhibitory activity and molecular docking studies of 3-hetroarylcoumarin derivatives. Eur. J. Med. Chem., 2011, 46, 1147-1152.
19. Gökhan-Kelekçi, N.; Simşek, O. O.; Ercan, A.; Yelekçi, K.; Sahin, Z. S.; Işik, S.; Uçar, G.; Bilgin, A. A.; Synthesis and molecular modeling of some novel hexahydroindazole derivatives as potent monoamine oxidase inhibitors. Bioorg. Med. Chem., 2009, 17, 6761-6772.
20. Strydom, B.; Bergh, J. J.; Petzer, J. P. 8-aryl and alkoxy caffeine analogues as inhibitors of monoamine oxidase. Eur. J. Med. Chem., 2011, 46, 3474-3485.
21. Distinto, S.; Yáñez, M.; Alcaro, S.; Cardia, M. C.; Gaspari, M.; Sanna, M. L; Meleddu, R.; Ortuso, F.; Kirchmair, J.; Markt, P.; Bolasco, A.; Wolber, G.; Secci, D.; Maccioni, E. Synthesis and biological assessment of novel 2-thiazolylhydrazones and computational analysis of their recognition by monoamine oxidase B. Eur. J. Med. Chem., 2012, 48, 284-295.
22. Legoabe, L.; Kruger, J.; Petzer, A.; Bergh, J. J.; Petzer, J. P. Monoamine oxidase inhibition by selected anilide derivatives. Eur. J. Med. Chem., 2011, 46, 5162-5174.
23. Prins, L. H. A.; Petzer, J. P. Malan, S. F. Inhibition pf monoamine oxidase by indole and benzofuran derivatives. Eur. J. Med. Chem., 2010, 45, 4458-4466.
24. Lühr, S.; Vilches-Herrera, M.; Fierro, A.; Ramsay, R. R.; Edmondson, D. E.; Reyes-Parada, M.; Cassels, B. K.; Iturriaga-Vásquez, P. 2-Arylthiomorpholine derivatives as potent and selective monoamine oxidase B inhibitors. Bioorg. Med. Chem. 2010, 18, 1388-1395.
25. Khattab, S. N.; Hassan, S. Y.; Bekhit, A. A.; Massry, A. M. E.; Langer, V.; Amer, A. Synthesis of new series of quinoxaline based MAO-inhibitors and docking studies. Eur. J. Med. Chem., 2010, 45, 4479-4489.
26. Han, Y. N.; Noh, D. B.; Han, D. S. Studies on the monoamine oxidase inhibitors of medicinal plants I. Isolation of MAO-B inhibitors from Chrysanthemum indicum. Arch. Pharm. Res., 1987, 10, 142-147.
27. Ryu, S. Y.; Han, Y. N.; Han, B. H. Monoamine oxidase-A inhibitors from medicinal plants. Arch. Pharm. Res., 1988, 11, 230-239.
28. Haraguchi, H.; Tanaka, Y.; Kabbash, A.; Fujioka, T.; Ishizu, T.; Yagi, A. Monoamine oxidase inhibitors from Gentiana lutea. Phytochemistry, 2004, 65, 2255-2260.
29. Sloley, B. D.; Urichuk, L. J.; Morley, P.; Durkin, J.; Shan, J. J.; Pang, P. K.; Coutts, R. T. Identification of kaempferol as a monoamine oxidase inhibitor and potential neuroprotectant in extracts of Ginkgo biloba leaves. J. Pharm. Pharmacol., 2000, 52, 451-459.
30. Houa, W. C.; Lin, R. D.; Chena, C. T.; Lee, M. H. Monoamine oxidase B (MAO-B) inhibition by active principles from Uncaria rhynchophylla. J. Ethano. Pharmacol., 2005, 100, 216-220.
31. Hwang, J. S.; Lee, S. A; Hong, S. S.; Lee, K. S.; Lee, M. K.; Hwang, B. Y.; Ro, J. S. Monoamine oxidase inhibitory components from the roots of Sophora flavescens. Arch. Pharm. Res., 2005, 28, 190-194.
32. Chimenti, F.; Cottiglia, F.; Bonsignore, L.; Casu, L.; Casu, M.; Floris, C.; Secci, D.; Bolasco, A.; Chimenti, P.; Granese, A.; Befani, O.; Turini, P.; Alcaro, S.; Ortuso, F.; Trombetta, G.; Loizzo, A.; Guarino, I. Quercetin as the active principle of hypericum hircinum exerts a selective inhibitory activity against MAO-A: Extraction, biological analysis, and computational study. J. Nat. Prod., 2006, 69, 945-949.
33. Han, X. H.; Hong, S. S.; Hwang, J. S.; Lee, M. K.; Hwang, B. Y.; Ro, J. S. Monoamine oxidase inhibitory activity components from Cayratia japonica. Arch. Pharm. Res., 2007, 30, 13-17.
34. Olsen, H. T.; Stafford, G. I.; Johannes van Staden, J. V.; Christensen, S. B.; Jager, A. K.; Isolation of the MAO-inhibitor naringenin from Mentha aquatica L. J. Ethanopharmacol., 2008, 117, 500-502.
35. Youdim, K. A.; Qaiser, M. Z.; Begley, D. J.; Rice-Evans, C. A.; Abbott, N. J. Flavonoid permeability across an in situ model of the blood-brain barrier. Free Radic. Biol. Med., 2004, 36, 592-604.
36. Saaby, L.; Rasmussen, H. B.; Jager, A. K. MAO-A inhibitory activity of quercetin from Calluna vulgaris (L.) Hull. J. Ethanopharmacol., 2009, 121, 178-181.
37. Kong, L. D.; Cheng, C. H. K.; Tan, R. X. Monoamine oxidase inhibitors from rhizoma of Coptis chinensis. Planta Med., 2001, 67, 74-76.
38. Lee, S. S.; Kai, M.; Lee, M. K. Inhibitory effects of Sanguinarine on monoamine oxidase activity in mouse brain. Phytother. Res., 2001, 15, 167-169.
39. Kong, L. D.; Cheng, C. H. K.; Tan, R. X. Inhibition of MAO-A and B by some plant derived alkaloids, phenols and anthraquinones. J. Ethanopharmacol., 2004, 91, 351-355.
40. Herraiz, T.; Chaparro, C. Analysis of monoamine oxidase enzymatic activity by reversed-phase high performance liquid chromatography and inhibition by β-carboline alkaloids occurring in foods and plants. J. Chromatogr. A., 2006, 1120, 237-243.
41. Han, X. H.; Hong, S. S.; Lee, D.; Lee, J. J.; Lee, M. S.; Moon, D. C. Quinolone alkaloids from Evodiae fructus and their inhibitory effects on monoamine oxidase. Arch. Pharm. Res., 2007, 30, 397-401.
42. Lee, S. A.; Hwang, J. S.; Han, X. H.; Lee, C.; Lee, M. H.; Choe, S. G. Methylpiperate derivatives from piper longum and their inhibition of monoamine oxidase. Arch. Pharm. Res., 2008, 31, 679-683.
43. Al-Baghdadi, O. B.; Prater, N. I.; Van der Schyf, C. J.; Geldenhuys, W. J. Inhibition of monoamine oxidase by derivatives of piperine, an alkaloid from the pepper plant Piper nigrum, for possible use in Parkinson's disease. Bioorg. Med. Chem. Lett., 2012, 22, 7183-7188.
44. Passos, C. S.; Simões-Pires, C. A.; Nurisso, A.; Soldi, T. C.; Kato, L.; de Oliveira, C. M.; de Faria, E. O.; Marcourt, L.; Gottfried, C.; Carrupt, P. A.; Henriques, A. T. Indole alkaloids of Psychotria as multifunctional cholinesterases and monoamine oxidases inhibitors. Phytochemistry, 2013, 86, 8-20.
45. Rocha, L.; Marston, A.; Kaplan, A. C.; Evans, H. S.; Thull, U.; Testa B. An antifungal γ-pyrone and xanthones with monoamine oxidase inhibitory activity from Hypericum brasiliense. Phytochemistry, 1994, 36, 1381-1385.
46. Hwang, J. H.; Hong, S. S.; Han, X. H.; Hwang, J. S.; Lee, D.; Lee, H. Prenylated xanthones from the root bark of Cudrania tricuspidata. J. Nat. Prod., 2007, 70, 1207-1209.
47. Urbain, A.; Marston, A.; Grilo, L. S.; Bravo, J.; Purev, O.; Purevsuren, B.; Batsuren, D.; Reist, M.; Carrupt, P. A.; Hostettmann, K. Xanthones from Gentianella amarella ssp. acuta with acetylcholinesterase and monoamine oxidase inhibitory activities. J. Nat. Prod., 2008, 71, 895-897.